Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gielen

Alexander Gielen, Bandhagen SE

Patent application numberDescriptionPublished
20100285477Method for Predicting the Response to a Therapy - The invention concerns an in vitro method for selecting the therapy for a steroid resistant patient, wherein the method comprises isolating cells from a sample taken from said patient; cultivating said isolated cells in the presence of a steroid, an immunomodulatory oligonucleotide or a mixture thereof; determining an expression level of at least one marker gene in said isolated cells; and comparing said expression level of said at least one marker gene to a value obtained from the cultivation of cells from a healthy person in the presence of a steroid, an immunomodulatory oligonucleotide or a mixture thereof, or to a normalized value obtained from a healthy population. Examples of marker genes are CD163, Tsp1, IL1-R2, TLR2, TLR4, MKP-1 and TXK.11-11-2010
20110183337Method and Kit for Use in the Differentiation of IBD and IBS and Further Distinction Between Disease Types of IBD - A quantification of the expression levels of a number of specific genes and their corresponding proteins can be utilized in accurately determining, using samples from faeces or blood, whether the patient is suffering from irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD), and in a follow up analysis using a biopsy, determine if the same patient is afflicted with ulcerative colitis (UC) or Crohn's disease (CD). The method also has utility in determining the severity of the disease, as well as observing a patient's response to treatment.07-28-2011
20110293702Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS - Inflammatory diseases in the CNS can be treated or alleviated by the administration of an oligonucleotide in an amount sufficient to reduce the influx of mononuclear cells to the central nervous system by down-regulating the expression of at least one cell surface marker. For example multiple sclerosis can be treated or at least alleviated, by the administration of an oligonucleotide in a dose effective to inhibit or reduce the influx of mononuclear and/or autoaggressive cells to the central nervous system. The oligonucleotide can be used alone, or in combination with other treatment strategies.12-01-2011

Cornelis Gielen, Overpelt BE

Patent application numberDescriptionPublished
20090220471Solution for the biological cleaning of toothbrushes and corresponding device - A solution for the cleaning of toothbrushes consisting of a watery solution with a mixture of non-pathogenic gram-positive bacteria of the 09-03-2009

Cornelis Gielen, Lommel BE

Patent application numberDescriptionPublished
20090155890Use of non-pathogenic bacteria in their spore or dormant form to remove glycypharus droppings and allergic materials of all sorts of textile - The use and application of non-pathogenic bacteria in their spore or dormant form to remove glycyphagus droppings and other organic allergenic materials of any sorts of textile and in any environment they occur in and characterised by the fact that the non-pathogenic bacteria consume the glycyphagus droppings and organic allergenic materials and use these droppings as food, resulting in a permanent reduction of the droppings and resulting in a significant reduction of the allergen pressure in the areas to be cleaned.06-18-2009

Freddy Gielen, Rixensart BE

Patent application numberDescriptionPublished
20080207930Process For Producing a Chlorhydrin From a Multihydroxylated Aliphatic Hydrocarbon and/or Ester Thereof in the presence of Metal Salts - Process for producing a chlorohydrin by reaction between a multihydroxylated-aliphatic hydrocarbon, an ester of a multihydroxylated-aliphatic hydrocarbon, or a mixture thereof, and a chlorinating agent, according to which the multihydroxylated-aliphatic hydrocarbon, the ester of a multihydroxylated-aliphatic hydrocarbon, or the mixture thereof used contains at least one solid or dissolved metal salt, the process comprising a separation operation to remove at least part of the metal salt.08-28-2008
20120010420PROCESS FOR PRODUCING AN ORGANIC COMPOUND - Process for producing a chlorohydrin by reaction between a multihydroxylated-aliphatic hydrocarbon, an ester of a multihydroxylated-aliphatic hydrocarbon, or a mixture thereof, and a chlorinating agent, according to which the multihydroxylated-aliphatic hydrocarbon, the ester of a multihydroxylated-aliphatic hydrocarbon, or the mixture thereof used contains at least one solid or dissolved metal salt, the process comprising a separation operation to remove at least part of the metal salt.01-12-2012

Georges Gielen, Leuven BE

Patent application numberDescriptionPublished
20120086840DYNAMIC RANGE ENHANCEMENT - A method of increasing dynamic range of pixels in an imaging sensor is disclosed. In one aspect, two image captures are performed, one at a first short integration time and one at a second optimum integration time. An electrical value obtained from a pixel or group of pixels at the first short integration time is used to predict the second integration time using a comparison with a set of reference values. The reference values relate to a saturation electrical value for each pixel or group of pixels to predict the second integration time. The first short integration time is determined as a fractional multiple of the saturation electrical value. The second integration times are such that there is no saturation of the pixel or group of pixels. Adjustments can be made to the reference values to allow for offset immunity and variability in light levels during the second integration time.04-12-2012

Johannes Jacobus Ludgerus Gielen, Bouloc FR

Patent application numberDescriptionPublished
20090162904TRANSGENIC PLANTS AND METHODS FOR CONTROLLING BOLTING IN SUGAR BEET - This invention relates to the field of sugar beet bolting and flowering control, specifically methods and transgenic sugar beet plants for suppressing the vernalization response. In particular, the present invention includes sugar beet plants and methods for modulating sugar beet vernalization by over expression of an FLC gene or by suppressing AGL20 gene expression.06-25-2009
20090205073TRANSGENIC PLANTS AND METHODS FOR CONTROLLING BOLTING IN SUGAR BEET - This invention relates to the field of sugar beet bolting and flowering control, specifically methods and transgenic sugar beet plants for suppressing the vernalization response. In particular, the present invention includes sugar beet plants and methods for modulating sugar beet vernalization by over expression of an FLC gene or by suppressing AGL20 gene expression.08-13-2009
20100209919POLYNUCLEOTIDE MARKERS - The invention relates to polynucleotides that are closely linked to the bolting gene or B gene within the sugar beet genome and can be used for the development of molecular markers. The invention further relates to molecular markers and kits comprising said markers that can be used for mapping, identification and isolation of the bolting gene or S gene in the sugar beet genome and to discriminate between the annual and bienniai genotype or between different haplotypes within plant groupings of sugar beet plants exhibiting a biennial genotype. The invention also relates to assays and methods of breeding sugar beet plants involving said markers.08-19-2010
20110138492TRANSGENIC SUGAR BEET PLANTS - The invention relates to transgenic sugar beet plants having a phenotype of delayed bolting. The invention further relates to polynucleotides that are closely linked to the bolting gene or B gene within the sugar beet genome and can be used for the discrimination between the annual and biennial genotype or between different haplotypes within plant groupings of sugar beet plants exhibiting a biennial genotype.06-09-2011
20110231946ENGINEERING OF BOLTING RESISTANCE IN SUGAR BEET BY MEANS OF THE TRANSGENIC EXPRESSION OF THE BEET HOMOLOGUE OF FLOWERING TIME CONTROL GENE FT - This invention relates to the field of bolting and flowering time control in sugar beet, specifically to methods as well as nucleic acid molecules, chimeric constructs, and vectors for engineering bolting resistance in sugar beet by means of altering the expression of the 09-22-2011

Patent applications by Johannes Jacobus Ludgerus Gielen, Bouloc FR

Ludo Jean Pierre Gielen, Kessel-Lo BE

Patent application numberDescriptionPublished
20090276197TRANSFER PATH ANALYSIS11-05-2009

Markus Gielen, Lindau DE

Patent application numberDescriptionPublished
20090288732Method for clamping a weft thread in a jet weaving machine, in particular air-jet weaving machine, clamping device and jet weaving machine - A method and a clamping device for clamping a weft thread in a jet weaving machine are proposed. The weft thread wire or strand runs through the beginning section (11-26-2009